Global BCG Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global BCG Vaccine market size is predicted to grow from US$ 78.7 million in 2025 to US$ 94.8 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Market Drivers for BCG Vaccine:
High Prevalence of Tuberculosis (TB): The increasing incidence of TB, especially in densely populated and low-income countries, drives the demand for BCG vaccines to prevent the disease, particularly among children and healthcare workers.
Rising Awareness and Immunization Programs: Many governments and health organizations promote vaccination to control TB outbreaks, providing funding and infrastructure to distribute BCG vaccines widely, particularly in high-risk regions.
Growing Healthcare Investments in Emerging Markets: Expanding healthcare infrastructure and government spending in emerging economies have increased the availability and accessibility of the BCG vaccine.
Development of New TB Strains: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has highlighted the need for effective preventative measures like the BCG vaccine.
Market Challenges for BCG Vaccine:
Limited Efficacy in Adults: The BCG vaccine’s effectiveness diminishes in adults, as it primarily prevents severe forms of TB in children rather than pulmonary TB, which is common in adults.
Side Effects and Safety Concerns: For individuals with weakened immune systems, the live BCG vaccine may pose health risks, which restricts its use among certain populations.
Supply Chain Constraints: Manufacturing challenges and periodic shortages impact the availability of BCG vaccines in some regions, particularly low-income countries.
Competition from New Vaccines and Treatments: Research on new TB vaccines and alternative treatments could reduce the reliance on BCG, especially if future solutions offer broader protection across age groups.
LP Information, Inc. (LPI) ' newest research report, the “BCG Vaccine Industry Forecast” looks at past sales and reviews total world BCG Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccine sales for 2025 through 2031. With BCG Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BCG Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global BCG Vaccine market?
What factors are driving BCG Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine market opportunities vary by end market size?
How does BCG Vaccine break out by Type, by Application?
The global BCG Vaccine market size is predicted to grow from US$ 78.7 million in 2025 to US$ 94.8 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Market Drivers for BCG Vaccine:
High Prevalence of Tuberculosis (TB): The increasing incidence of TB, especially in densely populated and low-income countries, drives the demand for BCG vaccines to prevent the disease, particularly among children and healthcare workers.
Rising Awareness and Immunization Programs: Many governments and health organizations promote vaccination to control TB outbreaks, providing funding and infrastructure to distribute BCG vaccines widely, particularly in high-risk regions.
Growing Healthcare Investments in Emerging Markets: Expanding healthcare infrastructure and government spending in emerging economies have increased the availability and accessibility of the BCG vaccine.
Development of New TB Strains: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has highlighted the need for effective preventative measures like the BCG vaccine.
Market Challenges for BCG Vaccine:
Limited Efficacy in Adults: The BCG vaccine’s effectiveness diminishes in adults, as it primarily prevents severe forms of TB in children rather than pulmonary TB, which is common in adults.
Side Effects and Safety Concerns: For individuals with weakened immune systems, the live BCG vaccine may pose health risks, which restricts its use among certain populations.
Supply Chain Constraints: Manufacturing challenges and periodic shortages impact the availability of BCG vaccines in some regions, particularly low-income countries.
Competition from New Vaccines and Treatments: Research on new TB vaccines and alternative treatments could reduce the reliance on BCG, especially if future solutions offer broader protection across age groups.
LP Information, Inc. (LPI) ' newest research report, the “BCG Vaccine Industry Forecast” looks at past sales and reviews total world BCG Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccine sales for 2025 through 2031. With BCG Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BCG Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC – Institute of Vaccines and Medical Biologicals
- Queen Saovabha Mem. Inst
- Microgen
What is the 10-year outlook for the global BCG Vaccine market?
What factors are driving BCG Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine market opportunities vary by end market size?
How does BCG Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for BCG Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for BCG Vaccine by Country/Region, 2020, 2024 & 2031
2.2 BCG Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 BCG Vaccine Sales by Type
2.3.1 Global BCG Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global BCG Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global BCG Vaccine Sale Price by Type (2020-2025)
2.4 BCG Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 BCG Vaccine Sales by Application
2.5.1 Global BCG Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global BCG Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global BCG Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global BCG Vaccine Breakdown Data by Company
3.1.1 Global BCG Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global BCG Vaccine Sales Market Share by Company (2020-2025)
3.2 Global BCG Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global BCG Vaccine Revenue by Company (2020-2025)
3.2.2 Global BCG Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global BCG Vaccine Sale Price by Company
3.4 Key Manufacturers BCG Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine Product Location Distribution
3.4.2 Players BCG Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BCG VACCINE BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global BCG Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global BCG Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic BCG Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global BCG Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global BCG Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas BCG Vaccine Sales Growth
4.4 APAC BCG Vaccine Sales Growth
4.5 Europe BCG Vaccine Sales Growth
4.6 Middle East & Africa BCG Vaccine Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine Sales by Country
5.1.1 Americas BCG Vaccine Sales by Country (2020-2025)
5.1.2 Americas BCG Vaccine Revenue by Country (2020-2025)
5.2 Americas BCG Vaccine Sales by Type (2020-2025)
5.3 Americas BCG Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine Sales by Region
6.1.1 APAC BCG Vaccine Sales by Region (2020-2025)
6.1.2 APAC BCG Vaccine Revenue by Region (2020-2025)
6.2 APAC BCG Vaccine Sales by Type (2020-2025)
6.3 APAC BCG Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine by Country
7.1.1 Europe BCG Vaccine Sales by Country (2020-2025)
7.1.2 Europe BCG Vaccine Revenue by Country (2020-2025)
7.2 Europe BCG Vaccine Sales by Type (2020-2025)
7.3 Europe BCG Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine by Country
8.1.1 Middle East & Africa BCG Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa BCG Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa BCG Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa BCG Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine
10.3 Manufacturing Process Analysis of BCG Vaccine
10.4 Industry Chain Structure of BCG Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine Distributors
11.3 BCG Vaccine Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine Market Size Forecast by Region
12.1.1 Global BCG Vaccine Forecast by Region (2026-2031)
12.1.2 Global BCG Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global BCG Vaccine Forecast by Type (2026-2031)
12.7 Global BCG Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab BCG Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India BCG Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines BCG Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma BCG Vaccine Product Portfolios and Specifications
13.5.3 BioFarma BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma BCG Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec BCG Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin BCG Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals BCG Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva BCG Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC – Institute of Vaccines and Medical Biologicals
13.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
13.11.2 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product Portfolios and Specifications
13.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IVAC – Institute of Vaccines and Medical Biologicals Main Business Overview
13.11.5 IVAC – Institute of Vaccines and Medical Biologicals Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst BCG Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen BCG Vaccine Product Portfolios and Specifications
13.13.3 Microgen BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. BCG Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. BCG Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players ofTherapy Vaccine
Table 5. Global BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 6. Global BCG Vaccine Sales Market Share byType (2020-2025)
Table 7. Global BCG Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global BCG Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global BCG Vaccine Sale Price byType (2020-2025) & (US$/Dose)
Table 10. Global BCG Vaccine Sale by Application (2020-2025) & (K Dose)
Table 11. Global BCG Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global BCG Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global BCG Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global BCG Vaccine Sale Price by Application (2020-2025) & (US$/Dose)
Table 15. Global BCG Vaccine Sales by Company (2020-2025) & (K Dose)
Table 16. Global BCG Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global BCG Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global BCG Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global BCG Vaccine Sale Price by Company (2020-2025) & (US$/Dose)
Table 20. Key Manufacturers BCG Vaccine Producing Area Distribution and Sales Area
Table 21. Players BCG Vaccine Products Offered
Table 22. BCG Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global BCG Vaccine Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global BCG Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global BCG Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global BCG Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global BCG Vaccine Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global BCG Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global BCG Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global BCG Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 34. Americas BCG Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas BCG Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 37. Americas BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 38. APAC BCG Vaccine Sales by Region (2020-2025) & (K Dose)
Table 39. APAC BCG Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC BCG Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 42. APAC BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 43. Europe BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 44. Europe BCG Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 46. Europe BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa BCG Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 50. Middle East & Africa BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of BCG Vaccine
Table 52. Key Market Challenges & Risks of BCG Vaccine
Table 53. Key IndustryTrends of BCG Vaccine
Table 54. BCG Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. BCG Vaccine Distributors List
Table 57. BCG Vaccine Customer List
Table 58. Global BCG Vaccine SalesForecast by Region (2026-2031) & (K Dose)
Table 59. Global BCG Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 61. Americas BCG Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC BCG Vaccine SalesForecast by Region (2026-2031) & (K Dose)
Table 63. APAC BCG Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 65. Europe BCG Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa BCG Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global BCG Vaccine SalesForecast byType (2026-2031) & (K Dose)
Table 69. Global BCG Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global BCG Vaccine SalesForecast by Application (2026-2031) & (K Dose)
Table 71. Global BCG Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck BCG Vaccine Product Portfolios and Specifications
Table 74. Merck BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG Lab BCG Vaccine Product Portfolios and Specifications
Table 79. Japan BCG Lab BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India BCG Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ Vaccines BCG Vaccine Product Portfolios and Specifications
Table 89. AJ Vaccines BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarma BCG Vaccine Product Portfolios and Specifications
Table 94. BioFarma BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio Pharma BCG Vaccine Product Portfolios and Specifications
Table 99. GreenSignal Bio Pharma BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotec BCG Vaccine Product Portfolios and Specifications
Table 104. China National Biotec BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed Lublin BCG Vaccine Product Portfolios and Specifications
Table 109. Biomed Lublin BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112.Taj Pharmaceuticals Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113.Taj Pharmaceuticals BCG Vaccine Product Portfolios and Specifications
Table 114.Taj Pharmaceuticals BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 115.Taj Pharmaceuticals Main Business
Table 116.Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de Paiva BCG Vaccine Product Portfolios and Specifications
Table 119. Ataulpho de Paiva BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC – Institute of Vaccines and Medical Biologicals Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product Portfolios and Specifications
Table 124. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 125. IVAC – Institute of Vaccines and Medical Biologicals Main Business
Table 126. IVAC – Institute of Vaccines and Medical Biologicals Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. Inst BCG Vaccine Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. Inst BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Microgen BCG Vaccine Product Portfolios and Specifications
Table 134. Microgen BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
LIST OFFIGURES
Figure 1. Picture of BCG Vaccine
Figure 2. BCG Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global BCG Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. BCG Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. BCG Vaccine Sales Market Share by Country/Region (2024)
Figure 10. BCG Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture ofTherapy Vaccine
Figure 13. Global BCG Vaccine Sales Market Share byType in 2025
Figure 14. Global BCG Vaccine Revenue Market Share byType (2020-2025)
Figure 15. BCG Vaccine Consumed in Self-Procurement
Figure 16. Global BCG Vaccine Market: Self-Procurement (2020-2025) & (K Dose)
Figure 17. BCG Vaccine Consumed in UNICEF
Figure 18. Global BCG Vaccine Market: UNICEF (2020-2025) & (K Dose)
Figure 19. BCG Vaccine Consumed in Other
Figure 20. Global BCG Vaccine Market: Other (2020-2025) & (K Dose)
Figure 21. Global BCG Vaccine Sale Market Share by Application (2024)
Figure 22. Global BCG Vaccine Revenue Market Share by Application in 2025
Figure 23. BCG Vaccine Sales by Company in 2025 (K Dose)
Figure 24. Global BCG Vaccine Sales Market Share by Company in 2025
Figure 25. BCG Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global BCG Vaccine Revenue Market Share by Company in 2025
Figure 27. Global BCG Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global BCG Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas BCG Vaccine Sales 2020-2025 (K Dose)
Figure 30. Americas BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC BCG Vaccine Sales 2020-2025 (K Dose)
Figure 32. APAC BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe BCG Vaccine Sales 2020-2025 (K Dose)
Figure 34. Europe BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa BCG Vaccine Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas BCG Vaccine Sales Market Share by Country in 2025
Figure 38. Americas BCG Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas BCG Vaccine Sales Market Share byType (2020-2025)
Figure 40. Americas BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC BCG Vaccine Sales Market Share by Region in 2025
Figure 46. APAC BCG Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC BCG Vaccine Sales Market Share byType (2020-2025)
Figure 48. APAC BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe BCG Vaccine Sales Market Share by Country in 2025
Figure 57. Europe BCG Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe BCG Vaccine Sales Market Share byType (2020-2025)
Figure 59. Europe BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61.France BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa BCG Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa BCG Vaccine Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of BCG Vaccine in 2025
Figure 74. Manufacturing Process Analysis of BCG Vaccine
Figure 75. Industry Chain Structure of BCG Vaccine
Figure 76. Channels of Distribution
Figure 77. Global BCG Vaccine Sales MarketForecast by Region (2026-2031)
Figure 78. Global BCG Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global BCG Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 80. Global BCG Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global BCG Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global BCG Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for BCG Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for BCG Vaccine by Country/Region, 2020, 2024 & 2031
2.2 BCG Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 BCG Vaccine Sales by Type
2.3.1 Global BCG Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global BCG Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global BCG Vaccine Sale Price by Type (2020-2025)
2.4 BCG Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 BCG Vaccine Sales by Application
2.5.1 Global BCG Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global BCG Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global BCG Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global BCG Vaccine Breakdown Data by Company
3.1.1 Global BCG Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global BCG Vaccine Sales Market Share by Company (2020-2025)
3.2 Global BCG Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global BCG Vaccine Revenue by Company (2020-2025)
3.2.2 Global BCG Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global BCG Vaccine Sale Price by Company
3.4 Key Manufacturers BCG Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine Product Location Distribution
3.4.2 Players BCG Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BCG VACCINE BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global BCG Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global BCG Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic BCG Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global BCG Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global BCG Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas BCG Vaccine Sales Growth
4.4 APAC BCG Vaccine Sales Growth
4.5 Europe BCG Vaccine Sales Growth
4.6 Middle East & Africa BCG Vaccine Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine Sales by Country
5.1.1 Americas BCG Vaccine Sales by Country (2020-2025)
5.1.2 Americas BCG Vaccine Revenue by Country (2020-2025)
5.2 Americas BCG Vaccine Sales by Type (2020-2025)
5.3 Americas BCG Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine Sales by Region
6.1.1 APAC BCG Vaccine Sales by Region (2020-2025)
6.1.2 APAC BCG Vaccine Revenue by Region (2020-2025)
6.2 APAC BCG Vaccine Sales by Type (2020-2025)
6.3 APAC BCG Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine by Country
7.1.1 Europe BCG Vaccine Sales by Country (2020-2025)
7.1.2 Europe BCG Vaccine Revenue by Country (2020-2025)
7.2 Europe BCG Vaccine Sales by Type (2020-2025)
7.3 Europe BCG Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine by Country
8.1.1 Middle East & Africa BCG Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa BCG Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa BCG Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa BCG Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine
10.3 Manufacturing Process Analysis of BCG Vaccine
10.4 Industry Chain Structure of BCG Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine Distributors
11.3 BCG Vaccine Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine Market Size Forecast by Region
12.1.1 Global BCG Vaccine Forecast by Region (2026-2031)
12.1.2 Global BCG Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global BCG Vaccine Forecast by Type (2026-2031)
12.7 Global BCG Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab BCG Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India BCG Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines BCG Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma BCG Vaccine Product Portfolios and Specifications
13.5.3 BioFarma BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma BCG Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec BCG Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin BCG Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals BCG Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva BCG Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC – Institute of Vaccines and Medical Biologicals
13.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
13.11.2 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product Portfolios and Specifications
13.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IVAC – Institute of Vaccines and Medical Biologicals Main Business Overview
13.11.5 IVAC – Institute of Vaccines and Medical Biologicals Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst BCG Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen BCG Vaccine Product Portfolios and Specifications
13.13.3 Microgen BCG Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. BCG Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. BCG Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players ofTherapy Vaccine
Table 5. Global BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 6. Global BCG Vaccine Sales Market Share byType (2020-2025)
Table 7. Global BCG Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global BCG Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global BCG Vaccine Sale Price byType (2020-2025) & (US$/Dose)
Table 10. Global BCG Vaccine Sale by Application (2020-2025) & (K Dose)
Table 11. Global BCG Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global BCG Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global BCG Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global BCG Vaccine Sale Price by Application (2020-2025) & (US$/Dose)
Table 15. Global BCG Vaccine Sales by Company (2020-2025) & (K Dose)
Table 16. Global BCG Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global BCG Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global BCG Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global BCG Vaccine Sale Price by Company (2020-2025) & (US$/Dose)
Table 20. Key Manufacturers BCG Vaccine Producing Area Distribution and Sales Area
Table 21. Players BCG Vaccine Products Offered
Table 22. BCG Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global BCG Vaccine Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global BCG Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global BCG Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global BCG Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global BCG Vaccine Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global BCG Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global BCG Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global BCG Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 34. Americas BCG Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas BCG Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 37. Americas BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 38. APAC BCG Vaccine Sales by Region (2020-2025) & (K Dose)
Table 39. APAC BCG Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC BCG Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 42. APAC BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 43. Europe BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 44. Europe BCG Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 46. Europe BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa BCG Vaccine Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa BCG Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa BCG Vaccine Sales byType (2020-2025) & (K Dose)
Table 50. Middle East & Africa BCG Vaccine Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of BCG Vaccine
Table 52. Key Market Challenges & Risks of BCG Vaccine
Table 53. Key IndustryTrends of BCG Vaccine
Table 54. BCG Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. BCG Vaccine Distributors List
Table 57. BCG Vaccine Customer List
Table 58. Global BCG Vaccine SalesForecast by Region (2026-2031) & (K Dose)
Table 59. Global BCG Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 61. Americas BCG Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC BCG Vaccine SalesForecast by Region (2026-2031) & (K Dose)
Table 63. APAC BCG Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 65. Europe BCG Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa BCG Vaccine SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa BCG Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global BCG Vaccine SalesForecast byType (2026-2031) & (K Dose)
Table 69. Global BCG Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global BCG Vaccine SalesForecast by Application (2026-2031) & (K Dose)
Table 71. Global BCG Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck BCG Vaccine Product Portfolios and Specifications
Table 74. Merck BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG Lab BCG Vaccine Product Portfolios and Specifications
Table 79. Japan BCG Lab BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India BCG Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ Vaccines BCG Vaccine Product Portfolios and Specifications
Table 89. AJ Vaccines BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarma BCG Vaccine Product Portfolios and Specifications
Table 94. BioFarma BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio Pharma BCG Vaccine Product Portfolios and Specifications
Table 99. GreenSignal Bio Pharma BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotec BCG Vaccine Product Portfolios and Specifications
Table 104. China National Biotec BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed Lublin BCG Vaccine Product Portfolios and Specifications
Table 109. Biomed Lublin BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112.Taj Pharmaceuticals Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113.Taj Pharmaceuticals BCG Vaccine Product Portfolios and Specifications
Table 114.Taj Pharmaceuticals BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 115.Taj Pharmaceuticals Main Business
Table 116.Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de Paiva BCG Vaccine Product Portfolios and Specifications
Table 119. Ataulpho de Paiva BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC – Institute of Vaccines and Medical Biologicals Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product Portfolios and Specifications
Table 124. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 125. IVAC – Institute of Vaccines and Medical Biologicals Main Business
Table 126. IVAC – Institute of Vaccines and Medical Biologicals Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. Inst BCG Vaccine Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. Inst BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information, BCG Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Microgen BCG Vaccine Product Portfolios and Specifications
Table 134. Microgen BCG Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
LIST OFFIGURES
Figure 1. Picture of BCG Vaccine
Figure 2. BCG Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global BCG Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. BCG Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. BCG Vaccine Sales Market Share by Country/Region (2024)
Figure 10. BCG Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture ofTherapy Vaccine
Figure 13. Global BCG Vaccine Sales Market Share byType in 2025
Figure 14. Global BCG Vaccine Revenue Market Share byType (2020-2025)
Figure 15. BCG Vaccine Consumed in Self-Procurement
Figure 16. Global BCG Vaccine Market: Self-Procurement (2020-2025) & (K Dose)
Figure 17. BCG Vaccine Consumed in UNICEF
Figure 18. Global BCG Vaccine Market: UNICEF (2020-2025) & (K Dose)
Figure 19. BCG Vaccine Consumed in Other
Figure 20. Global BCG Vaccine Market: Other (2020-2025) & (K Dose)
Figure 21. Global BCG Vaccine Sale Market Share by Application (2024)
Figure 22. Global BCG Vaccine Revenue Market Share by Application in 2025
Figure 23. BCG Vaccine Sales by Company in 2025 (K Dose)
Figure 24. Global BCG Vaccine Sales Market Share by Company in 2025
Figure 25. BCG Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global BCG Vaccine Revenue Market Share by Company in 2025
Figure 27. Global BCG Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global BCG Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas BCG Vaccine Sales 2020-2025 (K Dose)
Figure 30. Americas BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC BCG Vaccine Sales 2020-2025 (K Dose)
Figure 32. APAC BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe BCG Vaccine Sales 2020-2025 (K Dose)
Figure 34. Europe BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa BCG Vaccine Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa BCG Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas BCG Vaccine Sales Market Share by Country in 2025
Figure 38. Americas BCG Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas BCG Vaccine Sales Market Share byType (2020-2025)
Figure 40. Americas BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC BCG Vaccine Sales Market Share by Region in 2025
Figure 46. APAC BCG Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC BCG Vaccine Sales Market Share byType (2020-2025)
Figure 48. APAC BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe BCG Vaccine Sales Market Share by Country in 2025
Figure 57. Europe BCG Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe BCG Vaccine Sales Market Share byType (2020-2025)
Figure 59. Europe BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61.France BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa BCG Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa BCG Vaccine Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa BCG Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries BCG Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of BCG Vaccine in 2025
Figure 74. Manufacturing Process Analysis of BCG Vaccine
Figure 75. Industry Chain Structure of BCG Vaccine
Figure 76. Channels of Distribution
Figure 77. Global BCG Vaccine Sales MarketForecast by Region (2026-2031)
Figure 78. Global BCG Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global BCG Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 80. Global BCG Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global BCG Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global BCG Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) BCG Vaccine Market 2018 Forecast to 2023
US$ 4,880.00
May 2018
108 pages
